Conditions: Urologic Diseases Urinary Bladder, Overactive Urinary Bladder Diseases
Keywords: Vesitrim Frequency Urgency Urgency incontinence Urinary incontinence Overactive Bladder (OAB) Micturition Mirabegron YM178 Vesicare Solifenacin
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1887
Healthy volunteers: no

Brief summary:
The purpose of the study was to assess the efficacy, safety and tolerability of mirabegron 50 mg versus (vs) solifenacin 5 mg in the treatment of patients with OAB who were dissatisfied with their treatment due to lack of efficacy.

Detailed description:

Arms:
arm 1: Participants who received mirabegron 50 mg once daily for 12 weeks. arm 2: Participants who received solifenacin 5 mg once daily for 12 weeks.

Interventions: intervention 1: Mirabegron intervention 2: Solifenacin succinate
Intervention descriptions: intervention 1: oral tablet intervention 2: oral tablet

Protocol document: